rs143769046

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_001571.6(IRF3):​c.829G>A​(p.Ala277Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00605 in 1,613,680 control chromosomes in the GnomAD database, including 39 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0044 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0062 ( 39 hom. )

Consequence

IRF3
NM_001571.6 missense

Scores

3
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4O:1

Conservation

PhyloP100: -0.533

Publications

12 publications found
Variant links:
Genes affected
IRF3 (HGNC:6118): (interferon regulatory factor 3) This gene encodes a member of the interferon regulatory transcription factor (IRF) family. The encoded protein is found in an inactive cytoplasmic form that upon serine/threonine phosphorylation forms a complex with CREBBP. This complex translocates to the nucleus and activates the transcription of interferons alpha and beta, as well as other interferon-induced genes. The protein plays an important role in the innate immune response against DNA and RNA viruses. Mutations in this gene are associated with Encephalopathy, acute, infection-induced, herpes-specific, 7. [provided by RefSeq, Sep 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011467636).
BP6
Variant 19-49662101-C-T is Benign according to our data. Variant chr19-49662101-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 495307.
BS2
High AC in GnomAd4 at 671 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IRF3NM_001571.6 linkc.829G>A p.Ala277Thr missense_variant Exon 6 of 8 ENST00000377139.8 NP_001562.1 Q14653-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IRF3ENST00000377139.8 linkc.829G>A p.Ala277Thr missense_variant Exon 6 of 8 1 NM_001571.6 ENSP00000366344.3 Q14653-1

Frequencies

GnomAD3 genomes
AF:
0.00441
AC:
671
AN:
152250
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00111
Gnomad AMI
AF:
0.0538
Gnomad AMR
AF:
0.00602
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000827
Gnomad FIN
AF:
0.00245
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00650
Gnomad OTH
AF:
0.00526
GnomAD2 exomes
AF:
0.00394
AC:
988
AN:
250464
AF XY:
0.00385
show subpopulations
Gnomad AFR exome
AF:
0.00105
Gnomad AMR exome
AF:
0.00420
Gnomad ASJ exome
AF:
0.000597
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00283
Gnomad NFE exome
AF:
0.00615
Gnomad OTH exome
AF:
0.00490
GnomAD4 exome
AF:
0.00622
AC:
9088
AN:
1461312
Hom.:
39
Cov.:
31
AF XY:
0.00607
AC XY:
4409
AN XY:
726898
show subpopulations
African (AFR)
AF:
0.000687
AC:
23
AN:
33472
American (AMR)
AF:
0.00515
AC:
230
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.000421
AC:
11
AN:
26116
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39684
South Asian (SAS)
AF:
0.00136
AC:
117
AN:
86242
European-Finnish (FIN)
AF:
0.00304
AC:
162
AN:
53282
Middle Eastern (MID)
AF:
0.00503
AC:
29
AN:
5764
European-Non Finnish (NFE)
AF:
0.00742
AC:
8244
AN:
1111684
Other (OTH)
AF:
0.00451
AC:
272
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
557
1114
1671
2228
2785
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
324
648
972
1296
1620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00440
AC:
671
AN:
152368
Hom.:
0
Cov.:
33
AF XY:
0.00434
AC XY:
323
AN XY:
74504
show subpopulations
African (AFR)
AF:
0.00111
AC:
46
AN:
41584
American (AMR)
AF:
0.00601
AC:
92
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000827
AC:
4
AN:
4834
European-Finnish (FIN)
AF:
0.00245
AC:
26
AN:
10632
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00650
AC:
442
AN:
68034
Other (OTH)
AF:
0.00520
AC:
11
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
39
78
117
156
195
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00451
Hom.:
1
Bravo
AF:
0.00467
TwinsUK
AF:
0.00917
AC:
34
ALSPAC
AF:
0.00778
AC:
30
ESP6500AA
AF:
0.00204
AC:
9
ESP6500EA
AF:
0.00640
AC:
55
ExAC
AF:
0.00362
AC:
439
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00567
EpiControl
AF:
0.00646

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

IRF3: BS1 -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7 Uncertain:1Other:1
Mar 14, 2018
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Sep 25, 2021
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

- -

IRF3-related disorder Benign:1
Mar 16, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.091
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.24
CADD
Benign
5.8
DANN
Benign
0.93
DEOGEN2
Benign
0.30
T;T;.;.;T;T;T;T;T;T
Eigen
Benign
-0.65
Eigen_PC
Benign
-0.81
FATHMM_MKL
Benign
0.059
N
LIST_S2
Benign
0.84
T;.;T;T;.;T;.;.;.;T
M_CAP
Benign
0.084
D
MetaRNN
Benign
0.011
T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
-0.21
T
MutationAssessor
Uncertain
2.2
.;M;.;M;M;M;.;.;.;.
PhyloP100
-0.53
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.54
.;N;.;.;N;.;.;.;.;.
REVEL
Uncertain
0.36
Sift
Benign
0.34
.;T;.;.;T;.;.;.;.;.
Sift4G
Benign
0.13
T;T;T;T;T;T;T;T;T;T
Polyphen
0.21
.;B;.;.;B;B;.;.;.;.
Vest4
0.14
MVP
0.95
MPC
0.54
ClinPred
0.0089
T
GERP RS
-0.52
RBP_binding_hub_radar
0.97
RBP_regulation_power_radar
2.0
Varity_R
0.14
gMVP
0.27
Mutation Taster
=81/19
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143769046; hg19: chr19-50165358; COSMIC: COSV106083179; COSMIC: COSV106083179; API